HARTFORD, Conn., Oct. 22, 2019 /PRNewswire/ -- Aetna, a CVS Health company (NYSE: CVS), announced its Medicare Advantage Prescription Drug (MAPD) plans have once again received higher-than-average ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback